Skip to main content

pediatric oncology

Video
10/12/2022
Dr Allison Aguado discusses current treatment options for pediatric primary hepatic malignancies, as well as her currently enrolling trial on clinical outcomes and quality of life after radioembolization in children with liver cancer.
Dr Allison Aguado discusses current treatment options for pediatric primary hepatic malignancies, as well as her currently enrolling trial on clinical outcomes and quality of life after radioembolization in children with liver cancer.
Dr Allison Aguado discusses...
10/12/2022
IO Learning
Research Reports
10/16/2017
Abstract: The Oncologic Drugs Advisory Committee recently voted 10-0 recommending to the Food and Drug Administration (FDA) the approval of the first chimeric antigen receptor T (CAR-T) therapy. We sought to better...
Abstract: The Oncologic Drugs Advisory Committee recently voted 10-0 recommending to the Food and Drug Administration (FDA) the approval of the first chimeric antigen receptor T (CAR-T) therapy. We sought to better...
...
10/16/2017
Journal of Clinical Pathways
Research in Review
08/03/2017
JCP Editors
Consolidation with arsenic trioxide allows for decreased anthracycline dosing while maintaining survival rates and a low risk of relapse in pediatric patients with acute promyelocytic leukemia (APL), according to a...
Consolidation with arsenic trioxide allows for decreased anthracycline dosing while maintaining survival rates and a low risk of relapse in pediatric patients with acute promyelocytic leukemia (APL), according to a...
...
08/03/2017
Journal of Clinical Pathways